Opioid use has grown exponentially in the last 30 years. We aim to compare STEMI outcomes in patients with & without opioid use disorder (OUD). The national readmission database (2016-2020) was utilized to identify hospitalizations for STEMI. Cohorts were stratified by the presence of OUD. A Propensity Score Matching (PSM) model matched opioid users & non-users. Pearson's x2 test was applied to PSM-2 matched cohorts to compare outcomes. Among 1 million hospitalizations for STEMI; About 0.8% (N: 8,575) had OUD. After propensity matching (N=4,875), patients with OUD had higher mortality (13.4% vs 11.4%, aOR:1.27, p: 0.002); although rates of MI complications & sudden cardiac arrest were similar in the two cohorts (p>0.05). Opioid users were found to have lower utilization of PCA (70.5% vs 78.3%), PCI (48.9% vs 60.8%) & DES implantation (42.7% vs 53.4%) [p<0.001] but a higher bare metal stent/angioplasty (7.4% vs 5.6%, p:0.004). Opioid users had higher readmission rates on 30-day (13.7% vs 10%), 90 & 180-day intervals, higher LOS (4 vs 3 days) & cost of hospitalization [p<0.001]. Female gender (aOR: 1.23), DM (aOR: 1.37), ESKD (aOR: 2.2) & HF (aOR:1.6) were significant predictors of readmission while rehabilitation transfer was protective against readmissions (aOR:0.8) [p<0.001]. In STEMI hospitalizations, opioid users have higher mortality, lower rates of revascularizations, and higher readmission rates.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: